CC BY-NC-ND-license · Joints 2016; 04(03): 189-192
DOI: 10.11138/jts/2016.4.3.189
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Semitendinosus and gracilis free muscle-tendon graft for repair of massive rotator cuff tears: surgical technique

Antonio Gigante
1   Clinical Orthopaedics, Department of Clinical and Molecular Science DISClIMO, Polytechnic University of Marche, Ancona, Italy
,
Carlo Bottegoni
1   Clinical Orthopaedics, Department of Clinical and Molecular Science DISClIMO, Polytechnic University of Marche, Ancona, Italy
,
Giuseppe Milano
2   Department of Orthopaedics, Catholic University, “A. Gemelli” University Hospital, Rome, Italy
,
Michele Riccio
3   Department of Reconstructive Plastic Surgery - Hand Surgery, AOU “Ospedali Riuniti”, Ancona, Italy
,
Luca Dei Giudici
1   Clinical Orthopaedics, Department of Clinical and Molecular Science DISClIMO, Polytechnic University of Marche, Ancona, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
15 September 2017 (online)

Abstract

Massive rotator cuff tears are difficult to treat surgically due to retraction, degeneration and fraying of the ends of torn tendons, severe fatty infiltration and atrophy of the respective muscles.

Procedures developed to close the gap between the rotator cuff and the greater tuberosity of the humerus, such as soft tissue release may be inadequate for large tears. Human or porcine dermal allografts still have uncertain benefits, and tendon transfers seem to be associated with poor outcomes, donor site morbidity and altered mechanics. Reverse total shoulder arthroplasty has limited durability and is not indicated in young patients with high functional demands. We developed a new technique for repairing massive rotator cuff tears by semitendinosus and gracilis myotendinous grafting. This novel therapeutic option allows massive rotator cuff tears to be repaired using autologous material that is adequate and adaptable, making it possible to cover any width of defect. The technique is low-invasive and not technically demanding, with minimal donor site morbidity.